MARKET

LCI

LCI

Lannett Co
NYSE

Real-time Quotes | Nasdaq Last Sale

3.120
+0.040
+1.30%
Pre Market: 3.070 -0.05 -1.60% 09:19 09/24 EDT
OPEN
3.090
PREV CLOSE
3.080
HIGH
3.165
LOW
3.030
VOLUME
20.78K
TURNOVER
--
52 WEEK HIGH
10.70
52 WEEK LOW
2.880
MARKET CAP
131.90M
P/E (TTM)
-0.3389
1D
5D
1M
3M
1Y
5Y
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Benzinga · 09/10 13:44
Roth Capital Maintains Neutral on Lannett, Lowers Price Target to $6
Roth Capital analyst Scott Henry maintains Lannett (NYSE:LCI) with a Neutral and lowers the price target from $7 to $6.
Benzinga · 08/31 12:54
--Roth Capital Adjusts Lannett's Price Target to $6 from $7, Keeps Neutral Rating
MT Newswires · 08/31 10:20
New Strong Sell Stocks for August 30th
WKHS, EGLX, LCI, TTI, and PAA have been added to the Zacks Rank #5 (Strong Sell) List on August 30, 2021
Zacks · 08/30 15:56
Is There An Opportunity With Lannett Company, Inc.'s (NYSE:LCI) 30% Undervaluation?
Today we will run through one way of estimating the intrinsic value of Lannett Company, Inc. ( NYSE:LCI ) by taking the...
Simply Wall St. · 08/30 11:47
BRIEF-Lannett Commences Marketing Mycophenolate Mofetil For Oral Suspension
reuters.com · 08/30 11:12
Recap: Lannett Q4 Earnings
Shares of Lannett (NYSE:LCI) fell 13.3% in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 161.29% over the past year to ($0.19), which missed the estimate of ($0.12).
Benzinga · 08/26 14:02
Why Lannett Stock Is Plunging After Q4 Earnings Report?
Benzinga · 08/26 11:44
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LCI. Analyze the recent business situations of Lannett Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LCI stock price target is 6.00 with a high estimate of 6.00 and a low estimate of 6.00.
EPS
Institutional Holdings
Institutions: 185
Institutional Holdings: 32.64M
% Owned: 77.20%
Shares Outstanding: 42.28M
TypeInstitutionsShares
Increased
31
1.56M
New
15
1.96M
Decreased
34
9.28M
Sold Out
43
1.74M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.99%
Pharmaceuticals & Medical Research
+1.27%
Key Executives
Chairman/Independent Director
Patrick Lepore
Chief Executive Officer/Director
Timothy Crew
Chief Financial Officer/Chief Accounting Officer/Vice President - Finance
John Kozlowski
Chief Operating Officer/Vice President
John Abt
Senior Vice President
Maureen Cavanaugh
Vice President/Chief Information Officer
Robert Ehlinger
General Counsel
Samuel Israel
Director
Jeffrey Farber
Independent Director
John Chapman
Independent Director
David Drabik
Independent Director
Melissa Rewolinski
Independent Director
Paul Taveira
No Data
About LCI
Lannett Company, Inc. is a developer, manufacturer, marketer, and distributer of generic versions of brand pharmaceutical products for a range of medical indications. The Company's products include Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; Posaconazole DR Tablets, which are used to prevent fungal infections in people; Verapamil SR tablets are a calcium channel blocker used in the treatment of high blood pressure, arrhythmia and angina; Methylphenidate CD Capsules used for the treatment of Attention Deficit Hyperactivity Disorder; Omeprazole Capsules, which is indicated for the treatment of certain diseases of the esophagus and stomach ulcers; Pantoprazole Sodium DR Tablets, which is a proton pump inhibitor, indicated for the treatment of certain diseases of the esophagus and pathological hypersecretory conditions; and Sumatriptan Nasal Spray, which is indicated for the acute treatment of migraine attacks.

Webull offers kinds of Lannett Company, Inc. stock information, including NYSE:LCI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LCI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LCI stock methods without spending real money on the virtual paper trading platform.